Nuwellis, Inc. (NUWE)

Nuwellis, Inc. (NASDAQ:NUWE) Shares Shorted: Short Interest Up 339.6% in September

Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System

Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences

Nuwellis, Inc. (NASDAQ:NUWE) Sees Significant Decline in Short Interest

Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity

Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs

Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins

Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical

Nuwellis, Inc. (NUWE) Q2 2026 Earnings Call Prepared Remarks Transcript

Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin

Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth

Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies